Clinical Trial: A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Hereditary Pancreatitis Amlodipine Trial(H-PAT): A Pilot Study

Brief Summary: This pilot study is a feasibility, safety, and preliminary benefits study to look at whether giving the calcium channel blocker amlodipine to people with hereditary pancreatitis as a prophylactic measure can reduce the inflammatory process in the pancreas.